Scilex Holding Company saw its shares rise 18.79% after announcing that its Dream Bowl Meme Coin tokens could start trading on Biconomy Exchange as early as June 23. The listing is expected to boost liquidity and expand distribution to eligible token holders. Scilex, a biotech company focused on non-opioid pain management, distributed five Dream Bowl tokens per share to stockholders as of April 30. The stock closed at $5.88 and has gained over 100% in the past year, signaling strong investor interest ahead of the token trading launch.
Apollo Global Management reported record fee-related earnings of $785 million in Q2, a 25% increase year-over-year, with fee margins expanding to 58.5%. The company saw strong 34% growth in fee-generating assets under management and achieved a record...
In Austria, selling Bitcoin directly between private individuals is taxed the same as sales via crypto exchanges. The taxable event is the capital gain—the difference between sale proceeds and acquisition cost—with a 27.5% tax rate for Bitcoin acquir...
The U.S. SEC has approved Evernorth's registration, clearing the way for its $1 billion Nasdaq listing under the ticker XRPN through a merger with Armada Acquisition Corp. II. Evernorth plans to actively manage its XRP treasury to generate yield and ...
Amprius Technologies is benefiting from strong demand for drone batteries, reporting a 125.7% year-over-year revenue increase and improved gross margins. The company raised its 2026 revenue forecast to at least $140 million and aims for $600 million ...
INmune Bio is considered significantly undervalued with its treatment Ebstrocel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) driving a strong investment case. Ebstrocel offers systemic itch reduction, setting it apart from competitors like K...
